Skip to content

A STUDy TO MEASURE THE ROLE OF ISOSORBIDE MONONITRATE IN IUI CYCLES

EFFECT OF ISOSORBIDE MONONITRATE ON PREGNANCY RATE IN WOMEN UNDERGOING INTRAUTERINE INSEMINATION-A RANDOMIZED CONTROL STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/022618
Enrollment
60
Registered
2020-01-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

Intervention1: Isosorbide mononitrate: isosorbide mononitrate 10 mg given pervaginally in women undergoing IUI and measure its effects in the form of endometrial thickness,uterine artery blood flow in

Sponsors

Maulana azad medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Normal ovulatory cycles normal patent tubes normal semen analysis

Exclusion criteria

Exclusion criteria: Moderate to severe endometriosis active genital TB

Design outcomes

Primary

MeasureTime frame
Pregnancy rates in both study and control groupsTimepoint: After 2wks of IUI

Secondary

MeasureTime frame
Number of follicles on the day of trigger ,endometrial thickness,uterine artery blood flow indices,endometrial zonal blood flowTimepoint: on D2 AND TRIGGER DAY

Countries

India

Contacts

Public ContactSuma B

maulana azad medical college

drrtanwar@gmail.com9968604352

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026